CMO firm Recipharm has appointed Dr Giorgio Bruno as its new general manager of Recipharm Italia.
In this role, he will serve as CEO for all of Recipharm’s Italian operating companies which employ some 257 people at three sites and have revenues of €57m.
Dr Bruno has long established senior management experience from within the pharmaceutical industry, especially in the area of manufacturing.
He has worked in both Italian and multinational pharma companies covering a wide range of disciplines.
In particular he has had responsibility for quality and manufacturing at such companies including Parke Davis, AstraZeneca and Corden Pharma.
He holds a PhD in Pharmaceutical Chemistry and Technology from the University of Milan.
Thomas Eldered, CEO of Recipharm, said: “I am very pleased to welcome Dr Bruno to the Recipharm team. We are very fortunate to have been able to attract such a competent and highly experienced manager to this important position and I look forward to him bringing his expertise to bear across our Italian operations for which he is now responsible.”